References
- Armah, K. A., Chang, C. C. H., Baker, J. V., Ramachandran, V. S., Budoff, M. J., Crane, H. M., Gibert, C. L., Goetz, M. B., Leaf, D. A., McGinnis, K. A., Oursler, K. K., Rimland, D., Rodriguez-Barradas, M. C., Sico, J. J., Warner, A. L., Hsue, P. Y., Kuller, L. H., Justice, A. C., Freiberg, M. S., & Veterans Aging Cohort Study (VACS) Project Team. (2014). Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans. Clinical Infectious Diseases, 58(1), 121–129. https://doi.org/https://doi.org/10.1093/cid/cit652
- Batavia, A. S., Severe, P., Lee, M. H., Apollon, A., Zhu, Y. S., Dupnik, K. M., McNairy, M. L., Pape, J. W., Fitzgerald, D. W., & Peck, R. N. (2018). Blood pressure and mortality in a prospective cohort of HIV-infected adults in Port-au-Prince, Haiti. Journal of Hypertension, 36(7), 1533–1539. https://doi.org/https://doi.org/10.1097/HJH.0000000000001723
- Brown, T., Wang, Z. H., Palella, F., Wang, Z., Chu, H., Palella, F. J., Kingsley, L., Witt, M. D., & Dobs, A. S. (2006). Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43(3), 356–362. https://doi.org/https://doi.org/10.1097/01.qai.0000243052.73321.8e
- Chepchirchir, A., Jaoko, W., & Nyagol, J. (2018). Risk indicators and effects of hypertension on HIV/AIDS disease progression among patients seen at Kenyatta hospital HIV care center. AIDS Care, 30(5), 544–550. https://doi.org/https://doi.org/10.1080/09540121.2017.1384533
- Ding, Y., Lin, H., Liu, X., Zhang, Y., Wong, F. Y., Sun, Y. V., Marconi, V. C., & He, Na. (2017). Hypertension in HIV-infected adults compared with similar but uninfected adults in China: Body mass index-dependent effects of nadir CD4 count. AIDS Research and Human Retroviruses, 33(11), 1117–1125. https://doi.org/https://doi.org/10.1089/aid.2017.0008
- Fahme, S. A., Bloomfield, G. S., & Peck, R. (2018). Hypertension in HIV- infected adults: Novel pathophysiologic mechanisms. Hypertension, 72(1), 44–55. https://doi.org/https://doi.org/10.1161/HYPERTENSIONAHA.118.10893
- Freitas, P., Carvalho, D., Santos, A. C., Madureira, A. J., Xerinda, S., Martinez, E., Xerinda, S., Martinez, E., Pereira, J., Sarmento, A., & Medina, J. L. (2012). Central/peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients. The Journal of Clinical Hypertension, 14(9), 593–600. https://doi.org/https://doi.org/10.1111/j.1751-7176.2012.00671.x
- Gelpi, M., Afzal, S., Lundgren, J., Ronit, A., Roen, A., Mocroft, A., Gerstoft, J., Lebech, A-M., Lindegaard, B., Kofoed, K. F., Nordestgaard, B. G, & Nielsen, S. D. (2018). Higher risk of abdominal obesity, elevated low-density lipoprotein cholesterol, and hypertriglyceridemia, but not of hypertension, in people living with human immunodeficiency virus (HIV): Results from the Copenhagen Comorbidity in HIV infection study. Clinical Infectious Diseases, 67(4), 579–586. https://doi.org/https://doi.org/10.1093/cid/ciy146
- Hatleberg, C. I., Ryom, L., d'Arminio Monforte, A., Fontas, E., Reiss, P., Kirk, O., El-Sadr, W., Phillips, A., de Wit, S., Dabis, F., Weber, R., Law, M., Lundgren, J. D., Sabin, C. & Data collection on adverse events of Anti-HIV Drugs (D:A:D) study Group. (2018). Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: The data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. HIV Medicine, 19(9), 605–618. https://doi.org/https://doi.org/10.1111/hiv.12639
- Lake, J. E., Stanley, T. L., Apovian, C. M., Bhasin, S., Brown, T. T., Capeau, J., Currier, J. S., Dube, M. P., Falutz, J., Grinspoon, S. K., Guaraldi, G., Martinez, E., McComsey, G. A., Sattler, F. R., & Erlandson, K. M. (2017). Practical review of recognition and management of obesity and lipohypertrophy in human immunodeficiency virus infection. Clinical Infectious Diseases, 64(10), 1422–1429. https://doi.org/https://doi.org/10.1093/cid/cix178
- Lewington, S., Lacey, B., Clarke, R., Guo, Y., Kong, X. L., Yang, L. Chen, Y., Bian, Z., Chen, J., Meng, J., Xiong, Y., He, T., Pang, Z., Zhang, S., Collins, R., Peto, R., Li, L., Chen, Z., & China Kadoorie Biobank Consortium. (2016). The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Internal Medicine, 176(4), 524–532. https://doi.org/https://doi.org/10.1001/jamainternmed.2016.0190
- Lin, H., Ding, Y., Ning, C., Qiao, X., Chen, X., Chen, X., Shen, W., Liu, X., Hong, Y., & He, N. (2019). Age-specific associations between HIV infection and carotid artery intima-media thickness in China: A cross-sectional evaluation of baseline data from the CHART cohort. The Lancet HIV, 6(12), E860–E868. https://doi.org/https://doi.org/10.1016/S2352-3018(19)30263-2
- Ma, Y., Zhang, F., Zhao, Y., Zang, C., Zhao, D., Dou, Z., Yu, L., Fang, H., Zhu, T. Y., & Chen, R. Y. (2010). Cohort profile: The Chinese national free antiretroviral treatment cohort. International Journal of Epidemiology, 39(4), 973–979. https://doi.org/https://doi.org/10.1093/ije/dyp233
- Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J. (2016). Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation, 134(6), 441–450. https://doi.org/https://doi.org/10.1161/CIRCULATIONAHA.115.018912
- Okeke, N. L., Davy, T., Eron, J. J., & Napravnik, S. (2016). Hypertension among HIV-infected patients in clinical care, 1996–2013. Clinical Infectious Diseases, 63(2), 242–248. https://doi.org/https://doi.org/10.1093/cid/ciw223
- Okello, S., Kanyesigye, M., Muyindike, W. R., Annex, B. H., Hunt, P. W., Haneuse, S., & Siedner, M. J. (2015). Incidence and predictors of hypertension in adults with HIV-initiating antiretroviral therapy in south-western Uganda. Journal of Hypertension, 33(10), 2039–2045. https://doi.org/https://doi.org/10.1097/HJH.0000000000000657
- Srinivasa, S., Fitch, K., Wong, K., Torriani, M., Mayhew, C., Stanley, T., Lo, J., Adler, G. K., & Grinspoon, S. K. (2015). RAAS activation is associated with visceral adiposity and insulin resistance among HIV-infected patients. Journal of Clinical Endocrinology & Metabolism, 100(8), 2873–2882. https://doi.org/https://doi.org/10.1210/jc.2015-1461
- Thiébaut, R., El-Sadr, W. M., Friis-Møller, N., Rickenbach, M., Reiss, P., & Monforte, A. D. & Data Collection of Adverse events of anti-HIV Drugs study Group. (2005). Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antiviral Therapy, 10(7), 811–823.
- van Zoest, R. A., Wit, F. W., Kooij, K. W., van der Valk, M., Schouten, J., Kootstra, N. A, Wiersinga, W. J., Prins, M., van den Born, B-J. H., Reiss, P. & AGEhIV Cohort Study Group. (2016). Higher prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and prior stavudine exposure. Clinical Infectious Diseases, 63(2), 205–213. https://doi.org/https://doi.org/10.1093/cid/ciw285
- WHO. (2018). Disease burden and mortality estimates. https://apps.who.int/iris/handle/10665/44583/
- Writing Group of Chinese Guidelines for the Management of Hypertension. (2019). The 2018 Chinese guidelines for the management of hypertension. 24, 24–56.
- Xu, Y., Chen, X., & Wang, K. (2017). Global prevalence of hypertension among people living with HIV: A systematic review and meta-analysis. Journal of the American Society of Hypertension, 11(8), 530–540. https://doi.org/https://doi.org/10.1016/j.jash.2017.06.004
- Xu, Y., Chen, X., Zhou, Z., orano, M., & Cook, J., & L, R. (2019). The interaction between detectable plasma viral load and increased body mass index on hypertension among persons living with HIV. AIDS Care, 32(5), 890–895. doi:https://doi.org/10.1080/09540121.2019.1668521